Alkhatib G, Broder C C, Berger E A
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.
J Virol. 1996 Aug;70(8):5487-94. doi: 10.1128/JVI.70.8.5487-5494.1996.
Work in this laboratory previously demonstrated that the tropism of different human immunodeficiency type 1 isolates for infection of human CD4+ continuous cell lines (e.g., T-cell lines and HeLa-CD4 transformants) versus primary macrophages is associated with parallel intrinsic fusogenic specificities of the corresponding envelope glycoproteins (Envs). For T-cell line-tropic isolates, it is well established that the target cell must also contain a human-specific fusion cofactor(s) whose identity is unknown. In this study, we tested the hypothesis that the Env fusion specificities underlying T-cell line versus macrophage tropism are determined by distinct cell type-specific fusion cofactors. We applied a recombinant vaccinia virus-based reporter gene assay for Env-CD4-mediated cell fusion; the LAV and Ba-L Envs served as prototypes for T-cell line-tropic and macrophage-tropic isolates, respectively. We examined CD4+ promyeloctic and monocytic cell lines that are infectible by T-cell line-tropic isolates and become susceptible to macrophage-tropic strains only after treatment with differentiating agents. We observed parallel changes in fusion specificity: untreated cells supported fusion by the LAV but not the Ba-L Env, whereas cells treated with differentiating agents acquired fusion competence for Ba-L. These results suggest that in untreated cells, the block to infection by macrophage-tropic isolates is at the level of membrane fusion; furthermore, the differential regulation of fusion permissiveness for the two classes of Envs is consistent with the existence of distinct fusion cofactors. To test this notion directly, we conducted experiments with transient cell hybrids formed between CD4-expressing nonhuman cells (murine NIH 3T3) and different human cell types. Hybrids formed with HeLa cells supported fusion by the LAV Env but not by the Ba-L Env, whereas hybrids formed with primary macrophages showed the opposite specificity; hybrids formed between HeLa cells and macrophages supported fusion by both Envs. These results suggest the existence of cell type-specific fusion cofactors selective for each type of Env, rather than fusion inhibitors for discordant Env-cell combinations. Finally, analyses based on recombinant protein expression and antibody blocking did not support the proposals by others that the CD44 or CD26 antigens are involved directly in the entry of macrophage-tropic isolates.
本实验室先前的研究表明,不同的1型人类免疫缺陷病毒分离株对人类CD4⁺连续细胞系(如T细胞系和HeLa-CD4转化体)与原代巨噬细胞的感染嗜性,与相应包膜糖蛋白(Envs)平行的内在融合特异性相关。对于嗜T细胞系的分离株,已经明确靶细胞还必须含有一种身份未知的人类特异性融合辅助因子。在本研究中,我们检验了以下假设:嗜T细胞系与巨噬细胞嗜性背后的Env融合特异性由不同的细胞类型特异性融合辅助因子决定。我们应用了基于重组痘苗病毒的报告基因检测法来检测Env-CD4介导的细胞融合;LAV和Ba-L Envs分别作为嗜T细胞系和嗜巨噬细胞系分离株的原型。我们检测了可被嗜T细胞系分离株感染的CD4⁺早幼粒细胞系和单核细胞系,这些细胞系仅在经过分化剂处理后才对嗜巨噬细胞系毒株敏感。我们观察到融合特异性的平行变化:未处理的细胞支持LAV介导的融合,但不支持Ba-L Env介导的融合,而经分化剂处理的细胞获得了对Ba-L的融合能力。这些结果表明,在未处理的细胞中,嗜巨噬细胞系分离株的感染阻断发生在膜融合水平;此外,两类Env融合许可性的差异调节与不同融合辅助因子的存在一致。为了直接验证这一观点,我们用表达CD4的非人类细胞(小鼠NIH 3T3)与不同人类细胞类型形成的瞬时细胞杂种进行了实验。与HeLa细胞形成的杂种支持LAV Env介导的融合,但不支持Ba-L Env介导的融合,而与原代巨噬细胞形成的杂种表现出相反的特异性;HeLa细胞与巨噬细胞之间形成的杂种支持两种Env介导的融合。这些结果表明存在对每种Env具有选择性的细胞类型特异性融合辅助因子,而不是对不匹配的Env-细胞组合的融合抑制剂。最后,基于重组蛋白表达和抗体阻断的分析不支持其他人提出的CD44或CD26抗原直接参与嗜巨噬细胞系分离株进入的观点。